Jason Hoitt
Chief Patient Officer · Stoke Therapeutics, Inc.
- 2026
- Mar 19, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Hoitt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Adrian R. Krainer - $3.90M in STOK purchases and sales in the last 12 months
- Barry Ticho - $1.88M in STOK purchases and sales in the last 12 months
- Jonathan Allan - $1.20M in STOK purchases and sales in the last 12 months
- Edward M. Md Kaye - $934K in STOK purchases and sales in the last 12 months
- Arthur Tzianabos - $174K in STOK purchases and sales in the last 12 months
- Thomas Leggett - $147K in STOK purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason Hoitt?
Jason Hoitt is a corporate insider, tracked as Chief Patient Officer of Stoke Therapeutics, Inc. (STOK). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Jason Hoitt last file a Form 4?
The most recent primary Form 4 on record is dated 19 March 2026, one of 3 filings going back to 2026.
Has Jason Hoitt been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($119K) across all tracked filings.
